Ep 176 [21 May 2025]: Radek Wasiak PhD, Co-founder of Adigens Health and rAIRe(TM) – We discussed growth of regulator and payer acceptance of real-world evidence (RWE) with evolving frameworks supporting its use in regulatory and health technology assessment (HTA) decisions. In Asia and the Middle East, the adoption of RWE and related technologies is progressing even faster than US/EU, as health systems bypass legacy constraints and embrace innovative methods by default. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 175 [07 May 2025]: DB Kartik MBA, Executive Advisor at Cressey & Company – We discussed the evolution of RWE across pharma, and consolidation in RDW data, tech, and platforms. We also explored strategies for building and scaling RWE businesses, optimizing stakeholder value, and driving sustainable profitable growth ... including how aligning teams and staying true to core value propositions are key to success in RWE. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 174 [30 April 2025]: Kai Langel, CEO of DEEP Measures – We discussed the creation of DEEP Measures as well as the value of digital measures for health assessment in clinical trials and RWE studies specifically more broadly, given collaboration of organizations coming together with a shared vision to expand adoption and use of digital measures in research. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 173 [23 April 2025]: Farid Vij, Co-founder and CEO at Citizen Health – We discussed advances in patient-level data access and re-defining practical precision-medicine to yield better patient outcomes. Health can be elusive for many patients, a complex "equation" with more than one answer, but RWD and AI are helping to solve this complexity. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 171 [09 April 2025]: Rohit Mistry, CEO of IOMED – We explored his career journey into executive leadership and delve into key considerations for RWD access in the EU as well as health system engagement, while establishing robust data governance. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 172 [16 April 2025]: Cody Sam, co-founder and CEO of @Polytrial – We had an insightful conversation with Cody, who shared lessons learned from mapping clinical research protocols and building products to enhance and optimize operational delivery. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 169 [19 March 2025]: Prof. Siegal Sadetzki MD MPH M.Sc., leading public health practitioner & epidemiologist, and Chief Epidemiology Officer at Briya – We learned why Prof. Sadetzki believes RWD is the 21st-century take on modern epidemiology, merging traditional epi approaches with innovative big data methods. We discussed the advantages of digitalized, comprehensive real-world data and how it enhances population representation, full patient-journey tracking, and unlocks deeper scientific insights, optimizing clinical decision-making. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

Ep 170 [02 April 2025]: Christian Nguyen PharmD MS MBA—a visionary leader in real-world evidence and former SVP of Value Evidence & Outcomes at Lilly – We dove into the evolution of real-world data (RWD) into real-world evidence (RWE) and what it means for the future of drug development, market access, and patient care. Christian also shared firsthand experiences from the front lines of RWE generation, lessons learned, and the biggest gaps that still need to be addressed. Beyond the science, we explored career-defining moments and the business trends shaping the industry—how data-driven decision-making is transforming pharma and what professionals need to do to stay ahead. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.